Neuroimmunity of HTLV-I infection

57Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Human T-lymphotrophic virus type I (HTLV-I) is an oncogenic retrovirus and its infection is associated with a variety of human diseases including HTLV-I-associated myelopathy/tropic spastic paraparesis (HAM/TSP). Large numbers of epidemiological, virological, immunological, and clinical studies on HTLV-I- and HTLV-I-associated diseases have been published, although the pathogenesis of HAM/TSP remains to be fully understood. In the last several years, researchers have shown that several key factors are important in HTLV-I-associated neurologic disease including high HTLV-I proviral load and a strong immune response to HTLV-I. Here, we review pathophysiological findings on HAM/TSP and focus on viral-host immune responses to the virus in HTLV-I infected individuals. In particular, the role of HTLV-I-specific CD8+ T cell response is highlighted. © 2010 US Government.

Cite

CITATION STYLE

APA

Matsuura, E., Yamano, Y., & Jacobson, S. (2010, September). Neuroimmunity of HTLV-I infection. Journal of Neuroimmune Pharmacology. https://doi.org/10.1007/s11481-010-9216-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free